Leprosy in 21st century
References
Rao P N, Jain S. Newer management options in leprosy. Indian J Dermatol. 2013;58:6-11.
World Health Organization. Global leprosy situation, weekly epidemiological record. 2015;36:461-76
Ghayas AS, Saaiq M, Mahmood-ur-Rahman. Clinical observations in leprosy cases treated at Diamer district of Gilgit-Baltistan, Pakistan. J Pak Med Assoc.2013;63:1415-7.
Singal A, Sonthalia S. Leprosy in postelimination era in India: Difficult journey ahead. Indian J Dermatol. 2013;58:443-6.
Han XY, Silva FJ. On the age of leprosy. PLoS Negl Trop Dis. 2014;8(2):e2544.
White C, Franco-Paredes C. Leprosy in the 21st century. Clin Microbiol Rev. 2015;28:80-94.
Spencer JS, Brennan PJ. The role of Mycobacterium leprae phenolic glycolipid I (PGL-I) in serodiagnosis and in the pathogenesis of leprosy. Lepr Rev. 2011;82:344-57.
Geluk A, Duthie MS, Spencer JS. Postgenomic Mycobacterium leprae antigens for cellular and serological diagnosis of M. leprae exposure, infection and leprosy disease. Lepr Rev. 2011;82:402-21.
Duthie MS1, Balagon MF, Maghanoy A, Orcullo FM, Cang M, Dias RFet al. Rapid quantitative serological test for detection of infection with Mycobacterium leprae, the causative agent of leprosy. J Clin Microbiol. 2014;52:613-9.
Campos DC, Dutra AP, Suares VL, Carvalho PA, Camargo LM. New strategies for active finding of leprosy cases in the Amazonian region. Rev Soc Bras Med Trop. 2015;48:488-90.
Hacker MA, Duppre NC, Nery JA, Sales AM, Sarno EN. Characteristics of leprosy diagnosed through the surveillance of contacts: a comparison with index cases in Rio de Janeiro, 1987-2010. Mem Inst Oswaldo Cruz. 2012; 107:49-54.
Richardus JH, Oskam L. Protecting people against leprosy: chemoprophylaxis and immunoprophylaxis. Clin Dermatol. 2015;33:19-25.
Chaptini C, Marshman G. Leprosy: a review on elimination, reducing the disease burden, and future research. Lepr Rev. 2015;86:307-15.
